COVID-19 Outbreak-Global Antibody Drug Conjugate Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

November 2020 | 123 pages | ID: C2E5871AE7E9EN
Maia Research

Abstracts

The Antibody Drug Conjugate market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Antibody Drug Conjugate industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Antibody Drug Conjugate market can be split based on product types, major applications, and important countries as follows:

Key players in the global Antibody Drug Conjugate market covered in Chapter 12:

Mersana Therapeutics
Seattle Genetics/Takeda
Oxford BioTherapeutics
ImmunoGen
Heidelberg Pharma
Millennium Pharmaceuticals
Pfizer
Immunomedics
Takeda Pharmaceutical Company Limited
Celldex Therapeutics
Roche
Bayer HealthCare

In Chapter 4 and 14.1, on the basis of types, the Antibody Drug Conjugate market from 2015 to 2025 is primarily split into:

Adcetris
Kadcyl

In Chapter 5 and 14.2, on the basis of applications, the Antibody Drug Conjugate market from 2015 to 2025 covers:

Hospital
Research Institutions

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Contents

1 ANTIBODY DRUG CONJUGATE INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Antibody Drug Conjugate
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Antibody Drug Conjugate industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Antibody Drug Conjugate Market Size, 2015 – 2020
  2.1.2 Global Antibody Drug Conjugate Market Size by Type, 2015 – 2020
  2.1.3 Global Antibody Drug Conjugate Market Size by Application, 2015 – 2020
  2.1.4 Global Antibody Drug Conjugate Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Antibody Drug Conjugate Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Antibody Drug Conjugate Analysis
3.2 Major Players of Antibody Drug Conjugate
3.3 Antibody Drug Conjugate Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Antibody Drug Conjugate
  3.3.3 Labor Cost of Antibody Drug Conjugate
3.4 Market Distributors of Antibody Drug Conjugate
3.5 Major Downstream Buyers of Antibody Drug Conjugate Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL ANTIBODY DRUG CONJUGATE MARKET, BY TYPE

4.1 Global Antibody Drug Conjugate Value and Market Share by Type (2015-2020)
4.2 Global Antibody Drug Conjugate Production and Market Share by Type (2015-2020)
4.3 Global Antibody Drug Conjugate Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Antibody Drug Conjugate Value and Growth Rate of Adcetris
  4.3.2 Global Antibody Drug Conjugate Value and Growth Rate of Kadcyl
4.4 Global Antibody Drug Conjugate Price Analysis by Type (2015-2020)

5 ANTIBODY DRUG CONJUGATE MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Antibody Drug Conjugate Consumption and Market Share by Application (2015-2020)
5.3 Global Antibody Drug Conjugate Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Antibody Drug Conjugate Consumption and Growth Rate of Hospital (2015-2020)
  5.3.2 Global Antibody Drug Conjugate Consumption and Growth Rate of Research Institutions (2015-2020)

6 GLOBAL ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY REGIONS

6.1 Global Antibody Drug Conjugate Sales, Revenue and Market Share by Regions
  6.1.1 Global Antibody Drug Conjugate Sales by Regions (2015-2020)
  6.1.2 Global Antibody Drug Conjugate Revenue by Regions (2015-2020)
6.2 North America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.3 Europe Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.6 South America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

7 NORTH AMERICA ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Antibody Drug Conjugate Sales, Revenue and Market Share by Countries
  7.2.1 North America Antibody Drug Conjugate Sales by Countries (2015-2020)
  7.2.2 North America Antibody Drug Conjugate Revenue by Countries (2015-2020)
7.3 United States Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.4 Canada Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.5 Mexico Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

8 EUROPE ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Antibody Drug Conjugate Sales, Revenue and Market Share by Countries
  8.2.1 Europe Antibody Drug Conjugate Sales by Countries (2015-2020)
  8.2.2 Europe Antibody Drug Conjugate Revenue by Countries (2015-2020)
8.3 Germany Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.4 UK Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.5 France Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.6 Italy Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.7 Spain Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.8 Russia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Antibody Drug Conjugate Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Antibody Drug Conjugate Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Antibody Drug Conjugate Revenue by Countries (2015-2020)
9.3 China Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.4 Japan Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.5 South Korea Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.6 India Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.8 Australia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Antibody Drug Conjugate Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Antibody Drug Conjugate Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Antibody Drug Conjugate Revenue by Countries (2015-2020)
10.3 Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
10.4 UAE Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
10.5 Egypt Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
10.6 Nigeria Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
10.7 South Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Antibody Drug Conjugate Sales, Revenue and Market Share by Countries
  11.2.1 South America Antibody Drug Conjugate Sales by Countries (2015-2020)
  11.2.2 South America Antibody Drug Conjugate Revenue by Countries (2015-2020)
11.3 Brazil Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
11.4 Argentina Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
11.5 Columbia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
11.6 Chile Antibody Drug Conjugate Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Mersana Therapeutics
  12.1.1 Mersana Therapeutics Basic Information
  12.1.2 Antibody Drug Conjugate Product Introduction
  12.1.3 Mersana Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.2 Seattle Genetics/Takeda
  12.2.1 Seattle Genetics/Takeda Basic Information
  12.2.2 Antibody Drug Conjugate Product Introduction
  12.2.3 Seattle Genetics/Takeda Production, Value, Price, Gross Margin 2015-2020
12.3 Oxford BioTherapeutics
  12.3.1 Oxford BioTherapeutics Basic Information
  12.3.2 Antibody Drug Conjugate Product Introduction
  12.3.3 Oxford BioTherapeutics Production, Value, Price, Gross Margin 2015-2020
12.4 ImmunoGen
  12.4.1 ImmunoGen Basic Information
  12.4.2 Antibody Drug Conjugate Product Introduction
  12.4.3 ImmunoGen Production, Value, Price, Gross Margin 2015-2020
12.5 Heidelberg Pharma
  12.5.1 Heidelberg Pharma Basic Information
  12.5.2 Antibody Drug Conjugate Product Introduction
  12.5.3 Heidelberg Pharma Production, Value, Price, Gross Margin 2015-2020
12.6 Millennium Pharmaceuticals
  12.6.1 Millennium Pharmaceuticals Basic Information
  12.6.2 Antibody Drug Conjugate Product Introduction
  12.6.3 Millennium Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.7 Pfizer
  12.7.1 Pfizer Basic Information
  12.7.2 Antibody Drug Conjugate Product Introduction
  12.7.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.8 Immunomedics
  12.8.1 Immunomedics Basic Information
  12.8.2 Antibody Drug Conjugate Product Introduction
  12.8.3 Immunomedics Production, Value, Price, Gross Margin 2015-2020
12.9 Takeda Pharmaceutical Company Limited
  12.9.1 Takeda Pharmaceutical Company Limited Basic Information
  12.9.2 Antibody Drug Conjugate Product Introduction
  12.9.3 Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2015-2020
12.10 Celldex Therapeutics
  12.10.1 Celldex Therapeutics Basic Information
  12.10.2 Antibody Drug Conjugate Product Introduction
  12.10.3 Celldex Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.11 Roche
  12.11.1 Roche Basic Information
  12.11.2 Antibody Drug Conjugate Product Introduction
  12.11.3 Roche Production, Value, Price, Gross Margin 2015-2020
12.12 Bayer HealthCare
  12.12.1 Bayer HealthCare Basic Information
  12.12.2 Antibody Drug Conjugate Product Introduction
  12.12.3 Bayer HealthCare Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL ANTIBODY DRUG CONJUGATE MARKET FORECAST

14.1 Global Antibody Drug Conjugate Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Adcetris Market Value and Volume Forecast (2020-2025)
  14.1.2 Kadcyl Market Value and Volume Forecast (2020-2025)
14.2 Global Antibody Drug Conjugate Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Hospital Market Value and Volume Forecast (2020-2025)
  14.2.2 Research Institutions Market Value and Volume Forecast (2020-2025)
14.3 Antibody Drug Conjugate Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Drug Conjugate
Table Product Specification of Antibody Drug Conjugate
Table Antibody Drug Conjugate Key Market Segments
Table Key Players Antibody Drug Conjugate Covered
Figure Global Antibody Drug Conjugate Market Size, 2015 – 2025
Table Different Types of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Value ($) Segment by Type from 2015-2020
Figure Global Antibody Drug Conjugate Market Share by Types in 2019
Table Different Applications of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Value ($) Segment by Applications from 2015-2020
Figure Global Antibody Drug Conjugate Market Share by Applications in 2019
Figure Global Antibody Drug Conjugate Market Share by Regions in 2019
Figure North America Antibody Drug Conjugate Production Value ($) and Growth Rate (2015-2020)
Figure Europe Antibody Drug Conjugate Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Antibody Drug Conjugate Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Antibody Drug Conjugate Production Value ($) and Growth Rate (2015-2020)
Figure South America Antibody Drug Conjugate Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Antibody Drug Conjugate
Table Upstream Raw Material Suppliers of Antibody Drug Conjugate with Contact Information
Table Major Players Headquarters, and Service Area of Antibody Drug Conjugate
Figure Major Players Production Value Market Share of Antibody Drug Conjugate in 2019
Table Major Players Antibody Drug Conjugate Product Types in 2019
Figure Production Process of Antibody Drug Conjugate
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Channel Status of Antibody Drug Conjugate
Table Major Distributors of Antibody Drug Conjugate with Contact Information
Table Major Downstream Buyers of Antibody Drug Conjugate with Contact Information
Table Global Antibody Drug Conjugate Value ($) by Type (2015-2020)
Table Global Antibody Drug Conjugate Value Share by Type (2015-2020)
Figure Global Antibody Drug Conjugate Value Share by Type (2015-2020)
Table Global Antibody Drug Conjugate Production by Type (2015-2020)
Table Global Antibody Drug Conjugate Production Share by Type (2015-2020)
Figure Global Antibody Drug Conjugate Production Share by Type (2015-2020)
Figure Global Antibody Drug Conjugate Value ($) and Growth Rate of Adcetris (2015-2020)
Figure Global Antibody Drug Conjugate Value ($) and Growth Rate of Kadcyl (2015-2020)
Figure Global Antibody Drug Conjugate Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Antibody Drug Conjugate Consumption by Application (2015-2020)
Table Global Antibody Drug Conjugate Consumption Market Share by Application (2015-2020)
Figure Global Antibody Drug Conjugate Consumption Market Share by Application (2015-2020)
Figure Global Antibody Drug Conjugate Consumption and Growth Rate of Hospital (2015-2020)
Figure Global Antibody Drug Conjugate Consumption and Growth Rate of Research Institutions (2015-2020)
Figure Global Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Global Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table Global Antibody Drug Conjugate Sales by Regions (2015-2020)
Table Global Antibody Drug Conjugate Sales Market Share by Regions (2015-2020)
Table Global Antibody Drug Conjugate Revenue (M USD) by Regions (2015-2020)
Table Global Antibody Drug Conjugate Revenue Market Share by Regions (2015-2020)
Table Global Antibody Drug Conjugate Revenue Market Share by Regions in 2015
Table Global Antibody Drug Conjugate Revenue Market Share by Regions in 2019
Figure North America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Europe Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure South America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table North America Antibody Drug Conjugate Sales by Countries (2015-2020)
Table North America Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table North America Antibody Drug Conjugate Revenue (M USD) by Countries (2015-2020)
Table North America Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure United States Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Canada Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Mexico Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table Europe Antibody Drug Conjugate Sales by Countries (2015-2020)
Table Europe Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table Europe Antibody Drug Conjugate Revenue (M USD) by Countries (2015-2020)
Table Europe Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure Germany Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure UK Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure France Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Italy Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Spain Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Russia Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Antibody Drug Conjugate Sales by Countries (2015-2020)
Table Asia Pacific Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table Asia Pacific Antibody Drug Conjugate Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure China Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Japan Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure South Korea Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure India Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Southeast Asia Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Australia Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Middle East Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table Middle East Antibody Drug Conjugate Sales by Countries (2015-2020)
Table Middle East and Africa Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Antibody Drug Conjugate Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure UAE Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Egypt Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Nigeria Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure South Africa Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure South America Antibody Drug Conjugate Revenue (M USD) and Growth (2015-2020)
Table South America Antibody Drug Conjugate Sales by Countries (2015-2020)
Table South America Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table South America Antibody Drug Conjugate Revenue (M USD) by Countries (2015-2020)
Table South America Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure Brazil Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Argentina Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure Columbia Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Chile Antibody Drug Conjugate Sales and Growth (2015-2020)
Figure Top 3 Market Share of Antibody Drug Conjugate Companies in 2019
Figure Top 6 Market Share of Antibody Drug Conjugate Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Mersana Therapeutics Profile
Table Mersana Therapeutics Product Introduction
Figure Mersana Therapeutics Production and Growth Rate
Figure Mersana Therapeutics Value ($) Market Share 2015-2020
Table Seattle Genetics/Takeda Profile
Table Seattle Genetics/Takeda Product Introduction
Figure Seattle Genetics/Takeda Production and Growth Rate
Figure Seattle Genetics/Takeda Value ($) Market Share 2015-2020
Table Oxford BioTherapeutics Profile
Table Oxford BioTherapeutics Product Introduction
Figure Oxford BioTherapeutics Production and Growth Rate
Figure Oxford BioTherapeutics Value ($) Market Share 2015-2020
Table ImmunoGen Profile
Table ImmunoGen Product Introduction
Figure ImmunoGen Production and Growth Rate
Figure ImmunoGen Value ($) Market Share 2015-2020
Table Heidelberg Pharma Profile
Table Heidelberg Pharma Product Introduction
Figure Heidelberg Pharma Production and Growth Rate
Figure Heidelberg Pharma Value ($) Market Share 2015-2020
Table Millennium Pharmaceuticals Profile
Table Millennium Pharmaceuticals Product Introduction
Figure Millennium Pharmaceuticals Production and Growth Rate
Figure Millennium Pharmaceuticals Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Immunomedics Profile
Table Immunomedics Product Introduction
Figure Immunomedics Production and Growth Rate
Figure Immunomedics Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Product Introduction
Figure Takeda Pharmaceutical Company Limited Production and Growth Rate
Figure Takeda Pharmaceutical Company Limited Value ($) Market Share 2015-2020
Table Celldex Therapeutics Profile
Table Celldex Therapeutics Product Introduction
Figure Celldex Therapeutics Production and Growth Rate
Figure Celldex Therapeutics Value ($) Market Share 2015-2020
Table Roche Profile
Table Roche Product Introduction
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Table Bayer HealthCare Profile
Table Bayer HealthCare Product Introduction
Figure Bayer HealthCare Production and Growth Rate
Figure Bayer HealthCare Value ($) Market Share 2015-2020
Table Market Driving Factors of Antibody Drug Conjugate
Table Merger, Acquisition and New Investment
Table Global Antibody Drug Conjugate Market Value ($) Forecast, by Type
Table Global Antibody Drug Conjugate Market Volume Forecast, by Type
Figure Global Antibody Drug Conjugate Market Value ($) and Growth Rate Forecast of Adcetris (2020-2025)
Figure Global Antibody Drug Conjugate Market Volume ($) and Growth Rate Forecast of Adcetris (2020-2025)
Figure Global Antibody Drug Conjugate Market Value ($) and Growth Rate Forecast of Kadcyl (2020-2025)
Figure Global Antibody Drug Conjugate Market Volume ($) and Growth Rate Forecast of Kadcyl (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Research Institutions (2020-2025)
Figure Market Volume and Growth Rate Forecast of Research Institutions (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery